UBS Group »

Prime Medicine shares owned by UBS Group

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $278k 31k 8.86
2023-09-30 $418k 44k 9.54
2023-06-30 $1.5M 99k 14.65
2023-03-31 $61k 4.9k 12.31
2022-12-31 $23k 1.2k 18.58